Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cicletanine in Pulmonary Arterial Hypertension
NCT00832507Phase 2Terminated
- Sponsor
- Gilead Sciences
- Start
- Jan 2009
- Primary completion
- Oct 2011
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 2 trial of cicletanine in pulmonary arterial hypertension (PAH), sponsored by Gilead Sciences. Started Jan 2009; status: terminated.
02
Drugs
cicletanine
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT00832507.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00832507.